Current practices for ‘timing’ of physical therapy in Parkinson’s Disease: ‘Burst vs. Spaced’
Objective: To assess current practices for timing of physical therapy (PT) in Parkinson’s disease (PD). Background: Most persons with Parkinson disease (PD) face increasing mobility…Premenstrual worsening of UPDRS motor scale in women affected by Parkinson’s Disease
Objective: The role of estrogen in dopaminergic pathways and the premenstrual worsening of parkinsonian symptoms. Background: Female sex hormones, during the menstrual cycle, could influence…Characterization of at-home sleep macrostructure in Parkinson disease using a wearable sleep monitoring device
Objective: Determine the viability of a wearable reduced montage EEG device to record sleep in a population of patients with Parkinson disease (PD). Background: Sleep…Obesity is a protective factor for the development of Parkinson’s disease in participants of the Framingham Heart Study Cohort
Objective: To determine the role of obesity in the development of Parkinson's disease in a retrospective matched cohort study. Background: Parkinson’s disease (PD) is a…The High Prevalence of Developmental Vascular Anomalies in Parkinson’s Disease using USPIO-based MICRO MRI
Objective: To improve cerebral vascular visibility using an ultra-small super-paramagnetic iron oxide (USPIO) contrast agent and identify vascular abnormalities in patients with Parkinson’s disease (PD).…Prevalence and severity of non-motor symptoms in hispanic at-risk population with REM-sleep behavior disorder.
Objective: To detect non-motor symptoms in individuals at-risk for Parkinson's disease (PD) due to idiopathic REM sleep behavior disorder (RBD) and determine the rate of…Quantitative Evaluation of Seborrheic Dermatitis in Patients with Autonomic Dysfunction.
Objective: We quantitatively evaluated skin condition of patients with autonomic dysfunction. Background: Dyshidrosis are known to be one of autonomic symptom in Lewy body disease…Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?
Objective: To investigate gut microbiota alterations in Parkinson's disease (PD) along disease progression. Background: Gut microbiota dysbiosis is considered a hallmark in PD1. However, it is…Underutilization of Neurology and Rehabilitation Services among People with Parkinson’s Disease
Objective: to map utilization of neurology and rehabilitation services by people with Parkinson’s disease (PD), and to identify associations between utilization and demographics. Background: People…Safety and efficacy of P2B001 (low dose combination of extended-release pramipexole and rasagiline) in patients with early Parkinson’s disease: Subgroup analyses from a randomized, controlled trial
Objective: Evaluate the efficacy and safety of P2B001 for different subgroups of patients with early Parkinson’s disease (PD). Background: P2B001 is an investigational, fixed low-dose,…
- « Previous Page
- 1
- …
- 211
- 212
- 213
- 214
- 215
- …
- 436
- Next Page »